Hexamethyldisilazane
General Information
Mainterm | Hexamethyldisilazane |
CAS Reg.No.(or other ID) | 999-97-3 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 13838 |
IUPAC Name | [dimethyl-(trimethylsilylamino)silyl]methane |
InChI | InChI=1S/C6H19NSi2/c1-8(2,3)7-9(4,5)6/h7H,1-6H3 |
InChI Key | FFUAGWLWBBFQJT-UHFFFAOYSA-N |
Canonical SMILES | C[Si](C)(C)N[Si](C)(C)C |
Molecular Formula | C6H19NSi2 |
Wikipedia | hexamethyldisilazane |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 161.395 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 2 |
Complexity | 76.2 |
CACTVS Substructure Key Fingerprint | A A A D c e B i A A w A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A E B A R A A A A A A A A A A B C A A A A A A E A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 12.0 |
Monoisotopic Mass | 161.106 |
Exact Mass | 161.106 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 9 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9632 |
Human Intestinal Absorption | HIA+ | 0.7347 |
Caco-2 Permeability | Caco2+ | 0.5332 |
P-glycoprotein Substrate | Non-substrate | 0.8070 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9533 |
Non-inhibitor | 0.9923 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9266 |
Distribution | ||
Subcellular localization | Lysosome | 0.5078 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8071 |
CYP450 2D6 Substrate | Non-substrate | 0.8090 |
CYP450 3A4 Substrate | Non-substrate | 0.5900 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8174 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8612 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8855 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8194 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9303 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9285 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9420 |
Non-inhibitor | 0.9287 | |
AMES Toxicity | Non AMES toxic | 0.6150 |
Carcinogens | Carcinogens | 0.6678 |
Fish Toxicity | High FHMT | 0.6274 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.9342 |
Honey Bee Toxicity | High HBT | 0.6398 |
Biodegradation | Not ready biodegradable | 0.9173 |
Acute Oral Toxicity | III | 0.6414 |
Carcinogenicity (Three-class) | Non-required | 0.5742 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -1.1269 | LogS |
Caco-2 Permeability | 1.1743 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.1876 | LD50, mol/kg |
Fish Toxicity | 1.6755 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -0.9654 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organometallic compounds |
Class | Organometalloid compounds |
Subclass | Organosilicon compounds |
Intermediate Tree Nodes | Organoheterosilanes |
Direct Parent | Trialkylheterosilanes |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Trialkylheterosilane - N-silyl compound - Organic metalloid salt - Organic nitrogen compound - Hydrocarbon derivative - Organic salt - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as trialkylheterosilanes. These are organoheterosilanes, bearing a silicon atom linked to three alkyl groups and one heteroatom. |
From ClassyFire